ADMET |
absorption, distribution, metabolism, excretion and toxicity |
AMK |
amikacin |
AMPs |
antimicrobial peptides |
AMR |
antimicrobial resistance (AMR) |
ARCD |
antibiotic-resistant Clostridium difficile
|
attI |
recombination site |
AZT |
aztreonam |
BSI |
bloodstream infection |
CAZ |
ceftazidime |
CDI |
Clostridium difficile infections |
CFM |
cefixime |
CFZ |
cefazolin |
CPM |
cefepime |
CRE |
carbapenem-resistant Enterobacteriaceae spp. |
CREC |
carbapenem-resistant Escherichia coli
|
CRKP |
carbapenem-resistant Klebsiella pneumoniae
|
CTX |
cefotaxime |
EPS |
extracellular polymeric substances |
ESBL |
extended spectrum beta-lactamases |
ETP |
ertapenem |
FQ |
fluoroquinolone |
GEN |
gentamicin |
HGT |
horizontal gene transfer |
IMI |
imipenem |
intI |
integrase gene |
IS |
insertion sequences |
LGT |
lateral gene transfer |
MDR |
multidrug-resistant |
MEM |
meropenem |
MGEs |
mobile genetic elements |
MIC |
minimum inhibitory concentration |
MRG |
macrolide resistance genes |
MRSA |
methicillin-resistant Staphylococcus aureus
|
PBP |
Penicillin-binding proteins |
PDR |
pan-drug-resistant |
PTZ |
piperacillin-tazobactam |
rCDI |
relapse after Clostridium difficile infection |
SSI |
surgical site infection |
TEs |
transposable elements |
TET |
tetracycline |
TMT-SMX |
trimethoprim-sulfamethoxazole |
Tn |
transposons |
TOB |
tobramycin |
UTIs |
urinary tract infections |
VISA |
Staphylococcus aureus intermediate-resistant to vancomycin |
VRE |
vancomycin-resistant enterococci |
VRSA |
vancomycin-resistant Staphylococcus aureus
|
XDR |
Extensively drug-resistant |